Evolution of Biologics Screening Technologies
暂无分享,去创建一个
[1] R. Lequin. Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). , 2005, Clinical chemistry.
[2] Alessandro Spina. Pharmaceuticals , 2010, European Journal of Risk Regulation.
[3] Edward M. Goldberg,et al. Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay Technology , 1999, Journal of biomolecular screening.
[4] E. F. Ullman,et al. Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] Miqin Zhang,et al. Cellular impedance biosensors for drug screening and toxin detection. , 2007, The Analyst.
[6] N. Tinel,et al. A Fluorescent Ligand-Binding Alternative Using Tag-lite® Technology , 2010, Journal of biomolecular screening.
[7] C. Revankar,et al. A Homogeneous Fluorescent Live-Cell Assay for Measuring 7-Transmembrane Receptor Activity and Agonist Functional Selectivity Through Beta-Arrestin Recruitment , 2009, Journal of biomolecular screening.
[8] K. Olson,et al. A Homogeneous Enzyme Fragment Complementation-Based β-Arrestin Translocation Assay for High-Throughput Screening of G-Protein-Coupled Receptors , 2008, Journal of biomolecular screening.
[9] Neil D. Cook,et al. Scintillation proximity assay: a versatile high-throughput screening technology , 1996 .
[10] R. Karlsson,et al. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. , 1991, Journal of immunological methods.
[11] J. Pons,et al. Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet. , 2008, Analytical biochemistry.
[12] S. Manly,et al. Use of a Novel Homogeneous Fluorescent Technology in High Throughput Screening , 1996 .
[13] G. Winter,et al. Phage antibodies: filamentous phage displaying antibody variable domains , 1990, Nature.
[14] E. Diamandis,et al. Ultrasensitive bioanalytical assays using time-resolved fluorescence detection. , 1995, Pharmacology & therapeutics.
[15] Katherine A. Winters,et al. Fully Human Monoclonal Antibodies Antagonizing the Glucagon Receptor Improve Glucose Homeostasis in Mice and Monkeys , 2009, Journal of Pharmacology and Experimental Therapeutics.
[16] C. Hardman,et al. Modelling the human immune response: performance of a 1011 human antibody repertoire against a broad panel of therapeutically relevant antigens. , 2008, Protein engineering, design & selection : PEDS.
[17] Ye Fang,et al. Evaluation of dynamic mass redistribution technology for pharmacological studies of recombinant and endogenously expressed g protein-coupled receptors. , 2008, Assay and drug development technologies.
[18] Russell Garlick,et al. Development of Nonseparation Binding and Functional Assays for G Protein-Coupled Receptors for High Throughput Screening: Pharmacological Characterization of the Immobilized CCR5 Receptor on FlashPlate(r) , 1998 .
[19] J. Philip McCoy,et al. High-content screening: getting more from less , 2011, Nature Methods.
[20] T. Lövgren,et al. Europium as a label in time-resolved immunofluorometric assays. , 1984, Analytical biochemistry.
[21] Christopher B. Black,et al. Cell-based screening using high-throughput flow cytometry. , 2011, Assay and drug development technologies.